Our results demonstrate an overexpression of the functional markers IFN-γ and Granzyme B, as well as the inhibitory receptor KIR2DL1, on peripheral blood NK cells from severe COVID-19 patients, compared to uninfected controls. The gene discussed is KIR2DL1; the disease is COVID-19.